Commissioner Defends FDA On Duodenoscope, LDT Actions At Senate Hearing

In her last appearance before a Senate committee March 10, FDA Commissioner Margaret Hamburg presented a strong defense of FDA’s actions to address contaminated duodenoscopes, regulation of lab developed tests and other hot button issues raised by Senators, who also praised her leadership at FDA.

Outgoing FDA Commissioner Margaret Hamburg was challenged March 10 by members of the Senate Health, Education, Labor, and Pensions Committee on duodenoscopes involved in recent bacterial outbreaks and laboratory developed test regulations, among other hot button issues.

Hamburg, along with National Institutes of Health Director Francis Collins, was called before HELP to launch a series of hearings intended to identify reforms that could speed the path of...

More from Regulation

More from Policy & Regulation